3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Rectal Neoplasms
2
Prostatic Neoplasms
2
Lung Neoplasms
2
Leukemia
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms, Male
2
Adenocarcinoma Of Esophagus
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Multiple Myeloma
1
Liposarcoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Kidney Neoplasms
1
Gliosarcoma
1
Glioma, Subependymal
1
Glioma
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Interventions
Cytarabine
9
Etoposide
4
Daunorubicin
4
Idarubicin
3
Mitoxantrone
2
Gemtuzumab
2
Clofarabine
2
Asparaginase
2
tipifarnib
1
temsirolimus
1
palmitoyl-L-asparaginase
1
midostaurin
1
etoposide phosphate
1
eltrombopag
1
dexamethasone acetate
1
alvocidib
1
aldesleukin
1
Whole-Body Irradiation
1
Thioguanine
1
Proto-Oncogene Proteins c-kit
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Observation
1
Lenalidomide
1
Imatinib Mesylate
1
Gene Expression Profiling
1
Flow Cytometry
1
Filgrastim
1
Busulfan
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Eosinophilic, Acute
×
Reverse Transcriptase Polymerase Chain Reaction
×
Clear all
No trials found.